BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 20384478)

  • 1. Ocular gene therapy: an evaluation of recombinant adeno-associated virus-mediated gene therapy interventions for the treatment of ocular disease.
    Roy K; Stein L; Kaushal S
    Hum Gene Ther; 2010 Aug; 21(8):915-27. PubMed ID: 20384478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant AAV-mediated gene transfer to the retina: gene therapy perspectives.
    Rolling F
    Gene Ther; 2004 Oct; 11 Suppl 1():S26-32. PubMed ID: 15454954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vitro Evaluation of AAV Vectors for Retinal Gene Therapy.
    Wagner JE; Schön C; Becirovic E; Biel M; Michalakis S
    Methods Mol Biol; 2019; 1834():383-390. PubMed ID: 30324456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy for eye as regenerative medicine? Lessons from RPE65 gene therapy for Leber's Congenital Amaurosis.
    Rakoczy EP; Narfström K
    Int J Biochem Cell Biol; 2014 Nov; 56():153-7. PubMed ID: 25286304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in ocular gene therapy.
    Chung DC; Lee V; Maguire AM
    Curr Opin Ophthalmol; 2009 Sep; 20(5):377-81. PubMed ID: 19667988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AAV-mediated gene therapy for retinal disorders: from mouse to man.
    Buch PK; Bainbridge JW; Ali RR
    Gene Ther; 2008 Jun; 15(11):849-57. PubMed ID: 18418417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Comparison of Inducible Gene Expression Platforms: Implications for Recombinant Adeno-Associated Virus (rAAV) Vector-Mediated Ocular Gene Therapy.
    Lipinski DM
    Adv Exp Med Biol; 2019; 1185():79-83. PubMed ID: 31884592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postsurgical assessment and long-term safety of recombinant adeno-associated virus-mediated gene transfer into the retinas of dogs and primates.
    Le Meur G; Weber M; Péréon Y; Mendes-Madeira A; Nivard D; Deschamps JY; Moullier P; Rolling F
    Arch Ophthalmol; 2005 Apr; 123(4):500-6. PubMed ID: 15824224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene therapy for the eye focus on mutation-independent approaches.
    Dalkara D; Duebel J; Sahel JA
    Curr Opin Neurol; 2015 Feb; 28(1):51-60. PubMed ID: 25545056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adeno-associated virus-vectored gene therapy for retinal disease.
    Dinculescu A; Glushakova L; Min SH; Hauswirth WW
    Hum Gene Ther; 2005 Jun; 16(6):649-63. PubMed ID: 15960597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stable rAAV-mediated transduction of rod and cone photoreceptors in the canine retina.
    Bainbridge JW; Mistry A; Schlichtenbrede FC; Smith A; Broderick C; De Alwis M; Georgiadis A; Taylor PM; Squires M; Sethi C; Charteris D; Thrasher AJ; Sargan D; Ali RR
    Gene Ther; 2003 Aug; 10(16):1336-44. PubMed ID: 12883530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AAV-mediated gene transfer for retinal diseases.
    Allocca M; Tessitore A; Cotugno G; Auricchio A
    Expert Opin Biol Ther; 2006 Dec; 6(12):1279-94. PubMed ID: 17223737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adeno-associated viral vectors for retinal gene transfer and treatment of retinal diseases.
    Auricchio A; Rolling F
    Curr Gene Ther; 2005 Jun; 5(3):339-48. PubMed ID: 15975011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical gene therapy for the treatment of RPE65-associated Leber congenital amaurosis.
    Stein L; Roy K; Lei L; Kaushal S
    Expert Opin Biol Ther; 2011 Mar; 11(3):429-39. PubMed ID: 21299439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy in ophthalmology: validation on cultured retinal cells and explants from postmortem human eyes.
    Fradot M; Busskamp V; Forster V; Cronin T; Léveillard T; Bennett J; Sahel JA; Roska B; Picaud S
    Hum Gene Ther; 2011 May; 22(5):587-93. PubMed ID: 21142470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practical considerations of recombinant adeno-associated virus-mediated gene transfer for treatment of retinal degenerations.
    Shen WY; Lai CM; Lai YK; Zhang D; Zaknich T; Sutanto EN; Constable IJ; Rakoczy PE
    J Gene Med; 2003 Jul; 5(7):576-87. PubMed ID: 12825197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adeno-associated viral vectors and the retina.
    Alexander JJ; Hauswirth WW
    Adv Exp Med Biol; 2008; 613():121-8. PubMed ID: 18188936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant adeno-associated virus as delivery vector for gene therapy--a review.
    Lu Y
    Stem Cells Dev; 2004 Feb; 13(1):133-45. PubMed ID: 15068701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward exascale production of recombinant adeno-associated virus for gene transfer applications.
    Cecchini S; Negrete A; Kotin RM
    Gene Ther; 2008 Jun; 15(11):823-30. PubMed ID: 18401433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vectrology of adeno-associated viruses (AAV).
    Skubis-Zegadło J; Stachurska A; Małecki M
    Med Wieku Rozwoj; 2013; 17(3):202-6. PubMed ID: 24296444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.